Disease, Disability, and Injury Prevention and Control Special Emphasis Panel; Teleconference, 13621 [2011-5755]

Download as PDF Federal Register / Vol. 76, No. 49 / Monday, March 14, 2011 / Notices unit cost of materials, per unit cost of labor, per unit cost of design, test and certification, etc. Data from each manufacturer will be held confidential by the CPA and coded to remove corporate identifiers. The goal is to assess the cost of change to the industry rather than to an individual product within a given manufacturers’ broad product line. Candidate companies will be evaluated based on their capability and willingness to work cooperatively to achieve the stated goals. Candidates selected will be required to enter into a Letter of Agreement spelling out the level of participation expected of each partner and the handling of data generated from the partnership. This announcement does not obligate NIOSH to enter into an agreement with any respondents. NIOSH reserves the right to establish a partnership based on the engineering analysis and capabilities found by way of this announcement or other searches, if determined to be in the best interest of the government. NIOSH recognizes this opportunity will raise many questions for prospective partners. In order to give all involved the greatest opportunity to understand the process and project expectations, the NTEA–AMD, our collaborative partner and host standards setting body, has agreed to provide a meeting room for us to hold an informational meeting to present a broad overview of the effort and answer any resulting questions. In order to provide us with the best opportunity to meet the needs of all prospective partners at each of these meetings; we request that all interested parties contact Jim Green, NIOSH Project Officer, by e-mail at JGreen@cdc.gov; or telephone (304) 285–5857, by Thursday, March 17, 2011. mstockstill on DSKH9S0YB1PROD with NOTICES CONTACT PERSON FOR MORE INFORMATION: Jim Green, NIOSH Project Officer, email: JGreen@cdc.gov; telephone (304) 285–5857. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: March 7, 2011. Tanja Popovic, Deputy Associate Director for Science, Centers for Disease Control and Prevention. [FR Doc. 2011–5732 Filed 3–11–11; 8:45 am] BILLING CODE 4163–19–P VerDate Mar<15>2010 16:20 Mar 11, 2011 Jkt 223001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention 13621 Dated: March 7, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–5755 Filed 3–11–11; 8:45 am] Disease, Disability, and Injury Prevention and Control Special Emphasis Panel; Teleconference Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Pilot for Statespecific Cross-Sectional Surveillance of Persons with Rare Disorders and Longitudinal Assessment of Outcomes, Funding Opportunity Announcement (FOA) DD11–004, and Pilot Longitudinal Data Collection to Inform Public Health—Fragile X Syndrome, FOA DD11–007, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11 a.m.–5 p.m., April 21, 2011 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters to Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Pilot for State-specific Cross-Sectional Surveillance of Persons with Rare Disorders and Longitudinal Assessment of Outcomes, FOA DD11–004, and Pilot Longitudinal Data Collection to Inform Public Health—Fragile X Syndrome, FOA DD11–007.’’ Contact Person for More Information: Donald Blackman, PhD, Scientific Review Officer, Extramural Research Program Office, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, NE., Mailstop K–92, Atlanta, Georgia 30341, Telephone: (770) 488–3023, Email: DBY7@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Family History and Diamond Blackfan Anemia, DD11– 010, Initial Review Correction: This notice was published in the Federal Register on January 21, 2011, Volume 76, Number 14, Page 3909. The date for the aforementioned meeting has been changed to the following: DATES: April 27, 2011 (Closed). Contact Person for More Information: Michael Dalmat, Dr.P.H., Scientific Review Officer, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office of the Director, Extramural Research Program Office, 4770 Buford Highway, NE., Mailstop K– 92, Atlanta, Georgia 30341, Telephone: (770) 488–6423, E-mail: MED1@CDC.GOV. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: March 7, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–5759 Filed 3–11–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Opportunity to Partner; Testing of Patient Litters and Patient Restraints to Proposed Test Standard Authority: 29 U.S.C. 669. NIOSH, Centers for Disease Control and Prevention (CDC), AGENCY: E:\FR\FM\14MRN1.SGM 14MRN1

Agencies

[Federal Register Volume 76, Number 49 (Monday, March 14, 2011)]
[Notices]
[Page 13621]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-5755]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel; Teleconference

    Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Pilot for State-specific Cross-Sectional 
Surveillance of Persons with Rare Disorders and Longitudinal Assessment 
of Outcomes, Funding Opportunity Announcement (FOA) DD11-004, and Pilot 
Longitudinal Data Collection to Inform Public Health--Fragile X 
Syndrome, FOA DD11-007, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:
    Time and Date: 11 a.m.-5 p.m., April 21, 2011 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters to Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of ``Pilot for State-specific Cross-
Sectional Surveillance of Persons with Rare Disorders and Longitudinal 
Assessment of Outcomes, FOA DD11-004, and Pilot Longitudinal Data 
Collection to Inform Public Health--Fragile X Syndrome, FOA DD11-007.''
    Contact Person for More Information: Donald Blackman, PhD, 
Scientific Review Officer, Extramural Research Program Office, National 
Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 
Buford Highway, NE., Mailstop K-92, Atlanta, Georgia 30341, Telephone: 
(770) 488-3023, E-mail: DBY7@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: March 7, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-5755 Filed 3-11-11; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.